President Trump stunning his Republican base during a meeting with legislators Wednesday about Gun Control. "Take the guns first, go through due process second," said Trump during a bipartisan meeting at the White House. College Student Kassy Dillon, who founded Lone Conservative, reacts to Trump's departure from his base on this issue.
Twitter is asking the public to help it evaluate how toxic the social media platform really is. The announcement comes as Twitter, and other social platforms, are facing backlash over the growth of fake news on its sites. CNET Senior Reporter Ben Fox Rubin explains what Twitter is really trying to accomplish with this announcement.
In the wake of the Florida High School mass shooting, some Americans are looking for ways to take the issue of gun control into their own hands, or wallets. Todd Scorzafava is a Lead Partner of Wealth Management at Eagle Rock Wealth and he joins Cheddar to explain how investors can manage their funds in a socially-minded manner.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.
